Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan/Amlodipine Fixed Combination in Hypertension
NCT01625494Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan, amlodipine in hypertension (HTN), sponsored by Sanofi. Started May 2012; status: completed.
02
Drugs
irbesartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01625494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625494.